Non-liver-related mortality can be higher in NAFLD ‘depending on age, fibrosis stage’
A patient outcomes simulator found that non-liver-related mortality could surpass liver-related mortality in patients with nonalcoholic fatty liver disease, depending on age and fibrosis stage at diagnosis, noted data in JAMA Network Open.“NAFLD is a slowly progressive disease, therefore ongoing clinical trials evaluating NAFLD and NASH treatments use surrogate markers as primary end points,” Jagpreet Chhatwal, PhD, director of the Institute for Technology Assessment at Massachusetts General Hospital and assistant professor at Harvard Medical School, told Healio. “It isRead More
